Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Growth 2026-2032
The global Nicotinamide Mononucleotide (NMN) Facial Mask market size is predicted to grow from US$ 61.4 million in 2025 to US$ 207 million in 2032; it is expected to grow at a CAGR of 19.3% from 2026 to 2032.
The Nicotinamide Mononucleotide (NMN) Facial Mask market refers to the segment of the skincare and facial mask industry in which NMN is positioned as a key active ingredient for anti-aging and skin vitality. NMN (nicotinamide mononucleotide) is a precursor of NAD? and is recognized in cosmetic ingredient databases primarily as an antioxidant used in topical formulations. In NMN facial masks, this molecule is incorporated into sheet masks, hydrogel masks or cream/wash-off masks, usually in combination with collagen, hyaluronic acid, peptides and plant extracts, to claim benefits such as enhanced cellular energy metabolism, improved elasticity, hydration and reduction of fine lines. As a market, it includes any branded facial mask products that prominently feature NMN on the ingredient list, product name or marketing message and that are sold for regular home skincare routines or professional spa use.
The Nicotinamide Mononucleotide (NMN) Facial Mask industry chain runs from upstream producers of cosmetic-grade NMN, auxiliary actives (collagen, hyaluronic acid, peptides, plant extracts), non-woven or hydrogel mask substrates and packaging materials, through midstream cosmetic formulators and OEM/ODM mask manufacturers, to downstream brand owners, online and offline beauty retailers, spas and end-consumers using the masks for premium anti-aging and moisturizing facial care.
In 2024, global Nicotinamide Mononucleotide (NMN) Facial Mask production reached approximately 14.2 million units, with an average global market price of around US$ 3.7 per unit. The global single-line production capacity ranges from 1 to 2 millon units per year. The industry's gross profit margin is approximately 30%-35%.
United States market for Nicotinamide Mononucleotide (NMN) Facial Mask is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nicotinamide Mononucleotide (NMN) Facial Mask is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nicotinamide Mononucleotide (NMN) Facial Mask is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nicotinamide Mononucleotide (NMN) Facial Mask players cover Natuore Recover, Mirailab Bioscience, EffePharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
This Insight Report provides a comprehensive analysis of the global Nicotinamide Mononucleotide (NMN) Facial Mask landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotinamide Mononucleotide (NMN) Facial Mask portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotinamide Mononucleotide (NMN) Facial Mask market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotinamide Mononucleotide (NMN) Facial Mask and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotinamide Mononucleotide (NMN) Facial Mask.
This report presents a comprehensive overview, market shares, and growth opportunities of Nicotinamide Mononucleotide (NMN) Facial Mask market by product type, application, key manufacturers and key regions and countries.
The Nicotinamide Mononucleotide (NMN) Facial Mask market refers to the segment of the skincare and facial mask industry in which NMN is positioned as a key active ingredient for anti-aging and skin vitality. NMN (nicotinamide mononucleotide) is a precursor of NAD? and is recognized in cosmetic ingredient databases primarily as an antioxidant used in topical formulations. In NMN facial masks, this molecule is incorporated into sheet masks, hydrogel masks or cream/wash-off masks, usually in combination with collagen, hyaluronic acid, peptides and plant extracts, to claim benefits such as enhanced cellular energy metabolism, improved elasticity, hydration and reduction of fine lines. As a market, it includes any branded facial mask products that prominently feature NMN on the ingredient list, product name or marketing message and that are sold for regular home skincare routines or professional spa use.
The Nicotinamide Mononucleotide (NMN) Facial Mask industry chain runs from upstream producers of cosmetic-grade NMN, auxiliary actives (collagen, hyaluronic acid, peptides, plant extracts), non-woven or hydrogel mask substrates and packaging materials, through midstream cosmetic formulators and OEM/ODM mask manufacturers, to downstream brand owners, online and offline beauty retailers, spas and end-consumers using the masks for premium anti-aging and moisturizing facial care.
In 2024, global Nicotinamide Mononucleotide (NMN) Facial Mask production reached approximately 14.2 million units, with an average global market price of around US$ 3.7 per unit. The global single-line production capacity ranges from 1 to 2 millon units per year. The industry's gross profit margin is approximately 30%-35%.
United States market for Nicotinamide Mononucleotide (NMN) Facial Mask is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nicotinamide Mononucleotide (NMN) Facial Mask is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nicotinamide Mononucleotide (NMN) Facial Mask is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nicotinamide Mononucleotide (NMN) Facial Mask players cover Natuore Recover, Mirailab Bioscience, EffePharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Nicotinamide Mononucleotide (NMN) Facial Mask Industry Forecast” looks at past sales and reviews total world Nicotinamide Mononucleotide (NMN) Facial Mask sales in 2025, providing a comprehensive analysis by region and market sector of projected Nicotinamide Mononucleotide (NMN) Facial Mask sales for 2026 through 2032. With Nicotinamide Mononucleotide (NMN) Facial Mask sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nicotinamide Mononucleotide (NMN) Facial Mask industry.This Insight Report provides a comprehensive analysis of the global Nicotinamide Mononucleotide (NMN) Facial Mask landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotinamide Mononucleotide (NMN) Facial Mask portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotinamide Mononucleotide (NMN) Facial Mask market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotinamide Mononucleotide (NMN) Facial Mask and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotinamide Mononucleotide (NMN) Facial Mask.
This report presents a comprehensive overview, market shares, and growth opportunities of Nicotinamide Mononucleotide (NMN) Facial Mask market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Sheet Masks
- Hydrogel / jelly Masks
- Cream / paste-type Masks
- Others
Segmentation by Core Skin Benefit:
- Anti-aging NMN masks
- Hydrating NMN masks
- Brightening NMN masks
- Others
Segmentation by Target Consumer Group:
- 20s–30s Consumers
- 30s–40s Consumers
- Men Consumers
- Others
Segmentation by Mask Substrate:
- Conventional Non-woven Fabric Masks
- Bio-cellulose or Ferment-based Masks
- Hydrogel / film-forming Materials
- Others
Segmentation by Application:
- Online
- Offline
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Natuore Recover
- Mirailab Bioscience
- EffePharm
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Nicotinamide Mononucleotide (NMN) Facial Mask market?
- What factors are driving Nicotinamide Mononucleotide (NMN) Facial Mask market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Nicotinamide Mononucleotide (NMN) Facial Mask market opportunities vary by end market size?
- How does Nicotinamide Mononucleotide (NMN) Facial Mask break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) Facial Mask by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) Facial Mask by Country/Region, 2021, 2025 & 2032
2.2 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Type
2.2.1 Sheet Masks
2.2.2 Hydrogel / jelly Masks
2.2.3 Cream / paste-type Masks
2.2.4 Others
2.2.5 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type
2.2.5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
2.2.5.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Type (2021-2026)
2.3 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Core Skin Benefit
2.3.1 Anti-aging NMN masks
2.3.2 Hydrating NMN masks
2.3.3 Brightening NMN masks
2.3.4 Others
2.3.5 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Core Skin Benefit
2.3.5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Core Skin Benefit (2021-2026)
2.3.5.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Core Skin Benefit (2021-2026)
2.3.5.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Core Skin Benefit (2021-2026)
2.4 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Target Consumer Group
2.4.1 20s–30s Consumers
2.4.2 30s–40s Consumers
2.4.3 Men Consumers
2.4.4 Others
2.4.5 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Target Consumer Group
2.4.5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Target Consumer Group (2021-2026)
2.4.5.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Target Consumer Group (2021-2026)
2.4.5.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Target Consumer Group (2021-2026)
2.5 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Mask Substrate
2.5.1 Conventional Non-woven Fabric Masks
2.5.2 Bio-cellulose or Ferment-based Masks
2.5.3 Hydrogel / film-forming Materials
2.5.4 Others
2.5.5 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Mask Substrate
2.5.5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Mask Substrate (2021-2026)
2.5.5.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Mask Substrate (2021-2026)
2.5.5.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Mask Substrate (2021-2026)
2.6 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Application
2.6.1 Online
2.6.2 Offline
2.6.3 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application
2.6.3.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Market Share by Application (2021-2026)
2.6.3.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Application (2021-2026)
2.6.3.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Breakdown Data by Company
3.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales by Company (2021-2026)
3.1.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Company (2021-2026)
3.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue by Company (2021-2026)
3.2.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Company (2021-2026)
3.2.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Company (2021-2026)
3.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Company
3.4 Key Manufacturers Nicotinamide Mononucleotide (NMN) Facial Mask Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nicotinamide Mononucleotide (NMN) Facial Mask Product Location Distribution
3.4.2 Players Nicotinamide Mononucleotide (NMN) Facial Mask Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) FACIAL MASK BY GEOGRAPHIC REGION
4.1 World Historic Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Geographic Region (2021-2026)
4.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Country/Region (2021-2026)
4.2.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth
4.4 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth
4.5 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth
4.6 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth
5 AMERICAS
5.1 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country
5.1.1 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026)
5.1.2 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026)
5.2 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026)
5.3 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region
6.1.1 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region (2021-2026)
6.1.2 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region (2021-2026)
6.2 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026)
6.3 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nicotinamide Mononucleotide (NMN) Facial Mask by Country
7.1.1 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026)
7.1.2 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026)
7.2 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026)
7.3 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask by Country
8.1.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026)
8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026)
8.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) Facial Mask
10.3 Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN) Facial Mask
10.4 Industry Chain Structure of Nicotinamide Mononucleotide (NMN) Facial Mask
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nicotinamide Mononucleotide (NMN) Facial Mask Distributors
11.3 Nicotinamide Mononucleotide (NMN) Facial Mask Customer
12 WORLD FORECAST REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) FACIAL MASK BY GEOGRAPHIC REGION
12.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Size Forecast by Region
12.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Forecast by Region (2027-2032)
12.1.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nicotinamide Mononucleotide (NMN) Facial Mask Forecast by Type (2027-2032)
12.7 Global Nicotinamide Mononucleotide (NMN) Facial Mask Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Natuore Recover
13.1.1 Natuore Recover Company Information
13.1.2 Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
13.1.3 Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Natuore Recover Main Business Overview
13.1.5 Natuore Recover Latest Developments
13.2 Mirailab Bioscience
13.2.1 Mirailab Bioscience Company Information
13.2.2 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
13.2.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Mirailab Bioscience Main Business Overview
13.2.5 Mirailab Bioscience Latest Developments
13.3 EffePharm
13.3.1 EffePharm Company Information
13.3.2 EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
13.3.3 EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 EffePharm Main Business Overview
13.3.5 EffePharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) Facial Mask by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) Facial Mask by Country/Region, 2021, 2025 & 2032
2.2 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Type
2.2.1 Sheet Masks
2.2.2 Hydrogel / jelly Masks
2.2.3 Cream / paste-type Masks
2.2.4 Others
2.2.5 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type
2.2.5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
2.2.5.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Type (2021-2026)
2.3 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Core Skin Benefit
2.3.1 Anti-aging NMN masks
2.3.2 Hydrating NMN masks
2.3.3 Brightening NMN masks
2.3.4 Others
2.3.5 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Core Skin Benefit
2.3.5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Core Skin Benefit (2021-2026)
2.3.5.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Core Skin Benefit (2021-2026)
2.3.5.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Core Skin Benefit (2021-2026)
2.4 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Target Consumer Group
2.4.1 20s–30s Consumers
2.4.2 30s–40s Consumers
2.4.3 Men Consumers
2.4.4 Others
2.4.5 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Target Consumer Group
2.4.5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Target Consumer Group (2021-2026)
2.4.5.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Target Consumer Group (2021-2026)
2.4.5.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Target Consumer Group (2021-2026)
2.5 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Mask Substrate
2.5.1 Conventional Non-woven Fabric Masks
2.5.2 Bio-cellulose or Ferment-based Masks
2.5.3 Hydrogel / film-forming Materials
2.5.4 Others
2.5.5 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Mask Substrate
2.5.5.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Mask Substrate (2021-2026)
2.5.5.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Mask Substrate (2021-2026)
2.5.5.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Mask Substrate (2021-2026)
2.6 Nicotinamide Mononucleotide (NMN) Facial Mask Segment by Application
2.6.1 Online
2.6.2 Offline
2.6.3 Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application
2.6.3.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Market Share by Application (2021-2026)
2.6.3.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue and Market Share by Application (2021-2026)
2.6.3.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Breakdown Data by Company
3.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales by Company (2021-2026)
3.1.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Company (2021-2026)
3.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue by Company (2021-2026)
3.2.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Company (2021-2026)
3.2.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Company (2021-2026)
3.3 Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Company
3.4 Key Manufacturers Nicotinamide Mononucleotide (NMN) Facial Mask Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nicotinamide Mononucleotide (NMN) Facial Mask Product Location Distribution
3.4.2 Players Nicotinamide Mononucleotide (NMN) Facial Mask Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) FACIAL MASK BY GEOGRAPHIC REGION
4.1 World Historic Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Geographic Region (2021-2026)
4.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nicotinamide Mononucleotide (NMN) Facial Mask Market Size by Country/Region (2021-2026)
4.2.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth
4.4 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth
4.5 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth
4.6 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth
5 AMERICAS
5.1 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country
5.1.1 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026)
5.1.2 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026)
5.2 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026)
5.3 Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region
6.1.1 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region (2021-2026)
6.1.2 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region (2021-2026)
6.2 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026)
6.3 APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nicotinamide Mononucleotide (NMN) Facial Mask by Country
7.1.1 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026)
7.1.2 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026)
7.2 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026)
7.3 Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask by Country
8.1.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026)
8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026)
8.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) Facial Mask
10.3 Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN) Facial Mask
10.4 Industry Chain Structure of Nicotinamide Mononucleotide (NMN) Facial Mask
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nicotinamide Mononucleotide (NMN) Facial Mask Distributors
11.3 Nicotinamide Mononucleotide (NMN) Facial Mask Customer
12 WORLD FORECAST REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) FACIAL MASK BY GEOGRAPHIC REGION
12.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Market Size Forecast by Region
12.1.1 Global Nicotinamide Mononucleotide (NMN) Facial Mask Forecast by Region (2027-2032)
12.1.2 Global Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nicotinamide Mononucleotide (NMN) Facial Mask Forecast by Type (2027-2032)
12.7 Global Nicotinamide Mononucleotide (NMN) Facial Mask Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Natuore Recover
13.1.1 Natuore Recover Company Information
13.1.2 Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
13.1.3 Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Natuore Recover Main Business Overview
13.1.5 Natuore Recover Latest Developments
13.2 Mirailab Bioscience
13.2.1 Mirailab Bioscience Company Information
13.2.2 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
13.2.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Mirailab Bioscience Main Business Overview
13.2.5 Mirailab Bioscience Latest Developments
13.3 EffePharm
13.3.1 EffePharm Company Information
13.3.2 EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
13.3.3 EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 EffePharm Main Business Overview
13.3.5 EffePharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sheet Masks
Table 4. Major Players of Hydrogel / jelly Masks
Table 5. Major Players of Cream / paste-type Masks
Table 6. Major Players of Others
Table 7. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 8. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Table 9. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Type (2021-2026) & ($ million)
Table 10. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Type (2021-2026)
Table 11. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Anti-aging NMN masks
Table 13. Major Players of Hydrating NMN masks
Table 14. Major Players of Brightening NMN masks
Table 15. Major Players of Others
Table 16. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Core Skin Benefit (2021-2026) & (K Units)
Table 17. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Core Skin Benefit (2021-2026)
Table 18. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Core Skin Benefit (2021-2026) & ($ million)
Table 19. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Core Skin Benefit (2021-2026)
Table 20. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Core Skin Benefit (2021-2026) & (US$/Unit)
Table 21. Major Players of 20s–30s Consumers
Table 22. Major Players of 30s–40s Consumers
Table 23. Major Players of Men Consumers
Table 24. Major Players of Others
Table 25. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Target Consumer Group (2021-2026) & (K Units)
Table 26. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Target Consumer Group (2021-2026)
Table 27. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Target Consumer Group (2021-2026) & ($ million)
Table 28. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Target Consumer Group (2021-2026)
Table 29. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Target Consumer Group (2021-2026) & (US$/Unit)
Table 30. Major Players of Conventional Non-woven Fabric Masks
Table 31. Major Players of Bio-cellulose or Ferment-based Masks
Table 32. Major Players of Hydrogel / film-forming Materials
Table 33. Major Players of Others
Table 34. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Mask Substrate (2021-2026) & (K Units)
Table 35. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Mask Substrate (2021-2026)
Table 36. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Mask Substrate (2021-2026) & ($ million)
Table 37. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Mask Substrate (2021-2026)
Table 38. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Mask Substrate (2021-2026) & (US$/Unit)
Table 39. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale by Application (2021-2026) & (K Units)
Table 40. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Market Share by Application (2021-2026)
Table 41. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Application (2021-2026) & ($ million)
Table 42. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Application (2021-2026)
Table 43. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Application (2021-2026) & (US$/Unit)
Table 44. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Company (2021-2026) & (K Units)
Table 45. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Company (2021-2026)
Table 46. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Company (2021-2026) & ($ millions)
Table 47. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Company (2021-2026)
Table 48. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Company (2021-2026) & (US$/Unit)
Table 49. Key Manufacturers Nicotinamide Mononucleotide (NMN) Facial Mask Producing Area Distribution and Sales Area
Table 50. Players Nicotinamide Mononucleotide (NMN) Facial Mask Products Offered
Table 51. Nicotinamide Mononucleotide (NMN) Facial Mask Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 52. New Products and Potential Entrants
Table 53. Market M&A Activity & Strategy
Table 54. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Geographic Region (2021-2026) & (K Units)
Table 55. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share Geographic Region (2021-2026)
Table 56. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Geographic Region (2021-2026) & ($ millions)
Table 57. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Geographic Region (2021-2026)
Table 58. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country/Region (2021-2026) & (K Units)
Table 59. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country/Region (2021-2026)
Table 60. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country/Region (2021-2026) & ($ millions)
Table 61. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country/Region (2021-2026)
Table 62. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026) & (K Units)
Table 63. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country (2021-2026)
Table 64. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026) & ($ millions)
Table 65. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 66. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026) & (K Units)
Table 67. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region (2021-2026) & (K Units)
Table 68. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Region (2021-2026)
Table 69. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region (2021-2026) & ($ millions)
Table 70. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 71. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026) & (K Units)
Table 72. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026) & (K Units)
Table 73. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026) & ($ millions)
Table 74. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 75. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2021-2026)
Table 78. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 79. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026) & (K Units)
Table 80. Key Market Drivers & Growth Opportunities of Nicotinamide Mononucleotide (NMN) Facial Mask
Table 81. Key Market Challenges & Risks of Nicotinamide Mononucleotide (NMN) Facial Mask
Table 82. Key Industry Trends of Nicotinamide Mononucleotide (NMN) Facial Mask
Table 83. Nicotinamide Mononucleotide (NMN) Facial Mask Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Nicotinamide Mononucleotide (NMN) Facial Mask Distributors List
Table 86. Nicotinamide Mononucleotide (NMN) Facial Mask Customer List
Table 87. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Region (2027-2032) & (K Units)
Table 88. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Region (2027-2032) & ($ millions)
Table 89. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Country (2027-2032) & (K Units)
Table 90. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Region (2027-2032) & (K Units)
Table 92. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 93. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Country (2027-2032) & (K Units)
Table 94. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Country (2027-2032) & ($ millions)
Table 95. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Country (2027-2032) & (K Units)
Table 96. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Country (2027-2032) & ($ millions)
Table 97. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Type (2027-2032) & (K Units)
Table 98. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Type (2027-2032) & ($ millions)
Table 99. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Application (2027-2032) & (K Units)
Table 100. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Application (2027-2032) & ($ millions)
Table 101. Natuore Recover Basic Information, Nicotinamide Mononucleotide (NMN) Facial Mask Manufacturing Base, Sales Area and Its Competitors
Table 102. Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
Table 103. Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Natuore Recover Main Business
Table 105. Natuore Recover Latest Developments
Table 106. Mirailab Bioscience Basic Information, Nicotinamide Mononucleotide (NMN) Facial Mask Manufacturing Base, Sales Area and Its Competitors
Table 107. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
Table 108. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Mirailab Bioscience Main Business
Table 110. Mirailab Bioscience Latest Developments
Table 111. EffePharm Basic Information, Nicotinamide Mononucleotide (NMN) Facial Mask Manufacturing Base, Sales Area and Its Competitors
Table 112. EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
Table 113. EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. EffePharm Main Business
Table 115. EffePharm Latest Developments
Table 1. Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nicotinamide Mononucleotide (NMN) Facial Mask Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sheet Masks
Table 4. Major Players of Hydrogel / jelly Masks
Table 5. Major Players of Cream / paste-type Masks
Table 6. Major Players of Others
Table 7. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 8. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Table 9. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Type (2021-2026) & ($ million)
Table 10. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Type (2021-2026)
Table 11. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Anti-aging NMN masks
Table 13. Major Players of Hydrating NMN masks
Table 14. Major Players of Brightening NMN masks
Table 15. Major Players of Others
Table 16. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Core Skin Benefit (2021-2026) & (K Units)
Table 17. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Core Skin Benefit (2021-2026)
Table 18. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Core Skin Benefit (2021-2026) & ($ million)
Table 19. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Core Skin Benefit (2021-2026)
Table 20. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Core Skin Benefit (2021-2026) & (US$/Unit)
Table 21. Major Players of 20s–30s Consumers
Table 22. Major Players of 30s–40s Consumers
Table 23. Major Players of Men Consumers
Table 24. Major Players of Others
Table 25. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Target Consumer Group (2021-2026) & (K Units)
Table 26. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Target Consumer Group (2021-2026)
Table 27. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Target Consumer Group (2021-2026) & ($ million)
Table 28. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Target Consumer Group (2021-2026)
Table 29. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Target Consumer Group (2021-2026) & (US$/Unit)
Table 30. Major Players of Conventional Non-woven Fabric Masks
Table 31. Major Players of Bio-cellulose or Ferment-based Masks
Table 32. Major Players of Hydrogel / film-forming Materials
Table 33. Major Players of Others
Table 34. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Mask Substrate (2021-2026) & (K Units)
Table 35. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Mask Substrate (2021-2026)
Table 36. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Mask Substrate (2021-2026) & ($ million)
Table 37. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Mask Substrate (2021-2026)
Table 38. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Mask Substrate (2021-2026) & (US$/Unit)
Table 39. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale by Application (2021-2026) & (K Units)
Table 40. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Market Share by Application (2021-2026)
Table 41. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Application (2021-2026) & ($ million)
Table 42. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Application (2021-2026)
Table 43. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Application (2021-2026) & (US$/Unit)
Table 44. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Company (2021-2026) & (K Units)
Table 45. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Company (2021-2026)
Table 46. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Company (2021-2026) & ($ millions)
Table 47. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Company (2021-2026)
Table 48. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Price by Company (2021-2026) & (US$/Unit)
Table 49. Key Manufacturers Nicotinamide Mononucleotide (NMN) Facial Mask Producing Area Distribution and Sales Area
Table 50. Players Nicotinamide Mononucleotide (NMN) Facial Mask Products Offered
Table 51. Nicotinamide Mononucleotide (NMN) Facial Mask Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 52. New Products and Potential Entrants
Table 53. Market M&A Activity & Strategy
Table 54. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Geographic Region (2021-2026) & (K Units)
Table 55. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share Geographic Region (2021-2026)
Table 56. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Geographic Region (2021-2026) & ($ millions)
Table 57. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Geographic Region (2021-2026)
Table 58. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country/Region (2021-2026) & (K Units)
Table 59. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country/Region (2021-2026)
Table 60. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country/Region (2021-2026) & ($ millions)
Table 61. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country/Region (2021-2026)
Table 62. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026) & (K Units)
Table 63. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country (2021-2026)
Table 64. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026) & ($ millions)
Table 65. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 66. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026) & (K Units)
Table 67. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Region (2021-2026) & (K Units)
Table 68. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Region (2021-2026)
Table 69. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Region (2021-2026) & ($ millions)
Table 70. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 71. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026) & (K Units)
Table 72. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026) & (K Units)
Table 73. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Country (2021-2026) & ($ millions)
Table 74. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 75. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2021-2026)
Table 78. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Type (2021-2026) & (K Units)
Table 79. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Application (2021-2026) & (K Units)
Table 80. Key Market Drivers & Growth Opportunities of Nicotinamide Mononucleotide (NMN) Facial Mask
Table 81. Key Market Challenges & Risks of Nicotinamide Mononucleotide (NMN) Facial Mask
Table 82. Key Industry Trends of Nicotinamide Mononucleotide (NMN) Facial Mask
Table 83. Nicotinamide Mononucleotide (NMN) Facial Mask Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Nicotinamide Mononucleotide (NMN) Facial Mask Distributors List
Table 86. Nicotinamide Mononucleotide (NMN) Facial Mask Customer List
Table 87. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Region (2027-2032) & (K Units)
Table 88. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Region (2027-2032) & ($ millions)
Table 89. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Country (2027-2032) & (K Units)
Table 90. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Region (2027-2032) & (K Units)
Table 92. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 93. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Country (2027-2032) & (K Units)
Table 94. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Country (2027-2032) & ($ millions)
Table 95. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Country (2027-2032) & (K Units)
Table 96. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Country (2027-2032) & ($ millions)
Table 97. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Type (2027-2032) & (K Units)
Table 98. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Type (2027-2032) & ($ millions)
Table 99. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Forecast by Application (2027-2032) & (K Units)
Table 100. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Forecast by Application (2027-2032) & ($ millions)
Table 101. Natuore Recover Basic Information, Nicotinamide Mononucleotide (NMN) Facial Mask Manufacturing Base, Sales Area and Its Competitors
Table 102. Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
Table 103. Natuore Recover Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Natuore Recover Main Business
Table 105. Natuore Recover Latest Developments
Table 106. Mirailab Bioscience Basic Information, Nicotinamide Mononucleotide (NMN) Facial Mask Manufacturing Base, Sales Area and Its Competitors
Table 107. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
Table 108. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Mirailab Bioscience Main Business
Table 110. Mirailab Bioscience Latest Developments
Table 111. EffePharm Basic Information, Nicotinamide Mononucleotide (NMN) Facial Mask Manufacturing Base, Sales Area and Its Competitors
Table 112. EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Product Portfolios and Specifications
Table 113. EffePharm Nicotinamide Mononucleotide (NMN) Facial Mask Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. EffePharm Main Business
Table 115. EffePharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nicotinamide Mononucleotide (NMN) Facial Mask
Figure 2. Nicotinamide Mononucleotide (NMN) Facial Mask Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country/Region (2025)
Figure 10. Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sheet Masks
Figure 12. Product Picture of Hydrogel / jelly Masks
Figure 13. Product Picture of Cream / paste-type Masks
Figure 14. Product Picture of Others
Figure 15. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type in 2026
Figure 16. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Anti-aging NMN masks
Figure 18. Product Picture of Hydrating NMN masks
Figure 19. Product Picture of Brightening NMN masks
Figure 20. Product Picture of Others
Figure 21. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Core Skin Benefit in 2026
Figure 22. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Core Skin Benefit (2021-2026)
Figure 23. Product Picture of 20s–30s Consumers
Figure 24. Product Picture of 30s–40s Consumers
Figure 25. Product Picture of Men Consumers
Figure 26. Product Picture of Others
Figure 27. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Target Consumer Group in 2026
Figure 28. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Target Consumer Group (2021-2026)
Figure 29. Product Picture of Conventional Non-woven Fabric Masks
Figure 30. Product Picture of Bio-cellulose or Ferment-based Masks
Figure 31. Product Picture of Hydrogel / film-forming Materials
Figure 32. Product Picture of Others
Figure 33. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Mask Substrate in 2026
Figure 34. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Mask Substrate (2021-2026)
Figure 35. Nicotinamide Mononucleotide (NMN) Facial Mask Consumed in Online
Figure 36. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market: Online (2021-2026) & (K Units)
Figure 37. Nicotinamide Mononucleotide (NMN) Facial Mask Consumed in Offline
Figure 38. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market: Offline (2021-2026) & (K Units)
Figure 39. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Market Share by Application (2025)
Figure 40. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Application in 2026
Figure 41. Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Company in 2026 (K Units)
Figure 42. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Company in 2026
Figure 43. Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Company in 2026 ($ millions)
Figure 44. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Company in 2026
Figure 45. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Geographic Region (2021-2026)
Figure 46. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Geographic Region in 2026
Figure 47. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales 2021-2026 (K Units)
Figure 48. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Revenue 2021-2026 ($ millions)
Figure 49. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales 2021-2026 (K Units)
Figure 50. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Revenue 2021-2026 ($ millions)
Figure 51. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales 2021-2026 (K Units)
Figure 52. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue 2021-2026 ($ millions)
Figure 53. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales 2021-2026 (K Units)
Figure 54. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue 2021-2026 ($ millions)
Figure 55. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country in 2026
Figure 56. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2021-2026)
Figure 57. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Figure 58. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2021-2026)
Figure 59. United States Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 60. Canada Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 61. Mexico Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 62. Brazil Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 63. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Region in 2026
Figure 64. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Region (2021-2026)
Figure 65. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Figure 66. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2021-2026)
Figure 67. China Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 68. Japan Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 69. South Korea Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 70. Southeast Asia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 71. India Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 72. Australia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 73. China Taiwan Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 74. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country in 2026
Figure 75. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2021-2026)
Figure 76. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Figure 77. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2021-2026)
Figure 78. Germany Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 79. France Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 80. UK Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 81. Italy Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 82. Russia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 83. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country (2021-2026)
Figure 84. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Figure 85. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2021-2026)
Figure 86. Egypt Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 87. South Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 88. Israel Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 89. Turkey Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 90. GCC Countries Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 91. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) Facial Mask in 2026
Figure 92. Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN) Facial Mask
Figure 93. Industry Chain Structure of Nicotinamide Mononucleotide (NMN) Facial Mask
Figure 94. Channels of Distribution
Figure 95. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Forecast by Region (2027-2032)
Figure 96. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share Forecast by Region (2027-2032)
Figure 97. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share Forecast by Type (2027-2032)
Figure 98. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share Forecast by Type (2027-2032)
Figure 99. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share Forecast by Application (2027-2032)
Figure 100. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Nicotinamide Mononucleotide (NMN) Facial Mask
Figure 2. Nicotinamide Mononucleotide (NMN) Facial Mask Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country/Region (2025)
Figure 10. Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Sheet Masks
Figure 12. Product Picture of Hydrogel / jelly Masks
Figure 13. Product Picture of Cream / paste-type Masks
Figure 14. Product Picture of Others
Figure 15. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type in 2026
Figure 16. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Anti-aging NMN masks
Figure 18. Product Picture of Hydrating NMN masks
Figure 19. Product Picture of Brightening NMN masks
Figure 20. Product Picture of Others
Figure 21. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Core Skin Benefit in 2026
Figure 22. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Core Skin Benefit (2021-2026)
Figure 23. Product Picture of 20s–30s Consumers
Figure 24. Product Picture of 30s–40s Consumers
Figure 25. Product Picture of Men Consumers
Figure 26. Product Picture of Others
Figure 27. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Target Consumer Group in 2026
Figure 28. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Target Consumer Group (2021-2026)
Figure 29. Product Picture of Conventional Non-woven Fabric Masks
Figure 30. Product Picture of Bio-cellulose or Ferment-based Masks
Figure 31. Product Picture of Hydrogel / film-forming Materials
Figure 32. Product Picture of Others
Figure 33. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Mask Substrate in 2026
Figure 34. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Mask Substrate (2021-2026)
Figure 35. Nicotinamide Mononucleotide (NMN) Facial Mask Consumed in Online
Figure 36. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market: Online (2021-2026) & (K Units)
Figure 37. Nicotinamide Mononucleotide (NMN) Facial Mask Consumed in Offline
Figure 38. Global Nicotinamide Mononucleotide (NMN) Facial Mask Market: Offline (2021-2026) & (K Units)
Figure 39. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sale Market Share by Application (2025)
Figure 40. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Application in 2026
Figure 41. Nicotinamide Mononucleotide (NMN) Facial Mask Sales by Company in 2026 (K Units)
Figure 42. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Company in 2026
Figure 43. Nicotinamide Mononucleotide (NMN) Facial Mask Revenue by Company in 2026 ($ millions)
Figure 44. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Company in 2026
Figure 45. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Geographic Region (2021-2026)
Figure 46. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Geographic Region in 2026
Figure 47. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales 2021-2026 (K Units)
Figure 48. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Revenue 2021-2026 ($ millions)
Figure 49. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales 2021-2026 (K Units)
Figure 50. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Revenue 2021-2026 ($ millions)
Figure 51. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales 2021-2026 (K Units)
Figure 52. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue 2021-2026 ($ millions)
Figure 53. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales 2021-2026 (K Units)
Figure 54. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue 2021-2026 ($ millions)
Figure 55. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country in 2026
Figure 56. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2021-2026)
Figure 57. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Figure 58. Americas Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2021-2026)
Figure 59. United States Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 60. Canada Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 61. Mexico Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 62. Brazil Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 63. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Region in 2026
Figure 64. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Region (2021-2026)
Figure 65. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Figure 66. APAC Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2021-2026)
Figure 67. China Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 68. Japan Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 69. South Korea Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 70. Southeast Asia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 71. India Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 72. Australia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 73. China Taiwan Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 74. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country in 2026
Figure 75. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share by Country (2021-2026)
Figure 76. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Figure 77. Europe Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2021-2026)
Figure 78. Germany Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 79. France Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 80. UK Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 81. Italy Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 82. Russia Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 83. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Country (2021-2026)
Figure 84. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Type (2021-2026)
Figure 85. Middle East & Africa Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share by Application (2021-2026)
Figure 86. Egypt Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 87. South Africa Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 88. Israel Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 89. Turkey Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 90. GCC Countries Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Growth 2021-2026 ($ millions)
Figure 91. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) Facial Mask in 2026
Figure 92. Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN) Facial Mask
Figure 93. Industry Chain Structure of Nicotinamide Mononucleotide (NMN) Facial Mask
Figure 94. Channels of Distribution
Figure 95. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Forecast by Region (2027-2032)
Figure 96. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share Forecast by Region (2027-2032)
Figure 97. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share Forecast by Type (2027-2032)
Figure 98. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share Forecast by Type (2027-2032)
Figure 99. Global Nicotinamide Mononucleotide (NMN) Facial Mask Sales Market Share Forecast by Application (2027-2032)
Figure 100. Global Nicotinamide Mononucleotide (NMN) Facial Mask Revenue Market Share Forecast by Application (2027-2032)
